期刊文献+

奈达铂联合氟尿嘧啶治疗晚期食管癌的疗效观察 被引量:9

Observation on the efficacy of nedaplatin combined with 5-fluorouracil in treatment of advanced esophageal cancer
原文传递
导出
摘要 目的 比较奈达铂(NDP)与顺铂(DDP)联合氟尿嘧啶(5-Fu)对晚期食管癌的疗效及其不良反应.方法 61例晚期食管癌患者随机为分观察组(奈达铂组)30例,对照组(顺铂组)31例.奈达铂组给予NDP 80~100 mg/m2,静脉滴注,第1天,5-Fu 0.5 g/m2,静脉滴注,第1~5天 顺铂组给予DDP 80~100 mg/m2,分3 d静脉滴注,5-Fu 0.5 g/m2静脉滴注,第1~5天.每4周为一个化疗周期,2个化疗周期后评定疗效并比较.结果 观察组有效率56.7%,显著高于对照组的29.0%(P〈0.05) 观察组的胃肠道不良反应显著低于对照组(P〈0.05),但骨髓毒性显著高于对照组(P〈0.05).结论 NDP联合5-Fu对晚期食管癌有一定的疗效,较DDP联合5-Fu方案有一定优势,临床耐受性较好,可作为一线药物推荐. Objective To compare the efficacy of nedaplatin(NDP) and cisplatin( DDP) combined with 5-fluorouracil(S-Fu) in treatment of advanced esophageal cancer.Methods 61 patients with advanced esophageal cancer were divided into two groups randomly,the observation group(NDP group) were 30 cases and the control group (DDP group) were 31 cases.NDP group were given NDP(80 ~ 100mg/m2, intravenous drip, 1 day) and 5-Fu (0.5g/m2,intravenous drip,l~5 day) ,DDP group were given DDP(80 ~100mg/m2 ,devided into 3 days) and5-Fu ( 0.5 g/m2 , intravenous drip ,1~5 day).The cycles were repeated every 4 weeks, and the effects were assessed after 2 cycles.Results The remisson rate of the observation group was 56.1% ,significantly higher than that of the control group (29.0% ) ( P 〈0.05).The toxicity of the observation group was milder for gastrointestinal tract but more serious for bone marrow than that of the control group (all P 〈 0.05).Conclusion NDP was an effective platinum drug for esophageal carcinoma.The efficacy of nedaplatin combined with 5-Fu regimen was better than that of DDP combined with 5-Fu regimen,and it had a good clinical tolerance and could be recommended as the first-line drugs.
作者 刘永玲
出处 《中国基层医药》 CAS 2011年第12期1641-1643,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 食管肿瘤 奈达铂 顺铂 Esophageal neoplasm Nedaplatin Cisplatin
  • 相关文献

参考文献9

  • 1孙燕,石远凯.临床肿瘤内科手册.5版.北京:人民卫生出版社,2010:147-156.
  • 2Desoize B,Madoulet C.Particular aspects of platinum compounds used at present in cancer treatment.Crit Rev Oncol Hematol,2002,42(3):317-325.
  • 3Akaza H,Saijo N.Aibak,et al.Platinam compounds in cancer therapy-past,present,and future.Can To Kagaku Ryoho,2001,28 (5):625-635.
  • 4Kanai M,Matsumoto S,Nishimura T,et al.Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer.Int J Clin Oncol,2007,12(3):224-227.
  • 5Shibata S,Kawasaki H,Nakai M.Chemoradiotherapy using platinum analogs/5-Fu for advanced esophageal cancer.Can To Kagaku Ryoho,2002,29(12):2209-2212.
  • 6徐瑞华,史艳侠,管忠震,姜文奇,黄河,马智勇,王建华,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春.国产奈达铂治疗食管癌的Ⅱ期临床试验报告[J].癌症,2006,25(12):1565-1568. 被引量:44
  • 7刘向明,钱碧云,屈大望,姜宏景,马明全.奈达铂联合氟尿嘧啶治疗中晚期食管癌的临床观察[J].临床肿瘤学杂志,2006,11(6):437-439. 被引量:22
  • 8史晓宇,韩宇,周建华,王丽杰,白玉贤.奈达铂联合5-Fu与顺铂联合5-Fu治疗晚期食管癌的疗效对比[J].肿瘤防治研究,2008,35(5):358-360. 被引量:7
  • 9Hartmann JT,Lipp HP.Toxity of platinum compounds.Expert Opin Phamacother,2003,4(6):889-901.

二级参考文献18

  • 1王全助,杜京娟,石建华.奈达铂联合吉西他滨治疗晚期非小细胞肺癌[J].临床肿瘤学杂志,2004,9(6):637-638. 被引量:20
  • 2刘向明,屈大望,赵锡江,张熙曾,石洋,钱碧云,李崴.诺维苯及顺铂治疗中晚期食管癌的临床观察[J].天津医药,2005,33(5):310-311. 被引量:3
  • 3Inaba H,Tsuda t,Miyazaki A.Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophagealcancer[J].Nippon Shokakibyo Gakkai Zasshi,2002,99(10):1191-1196.
  • 4Shibata S,Kawasaki H,Nakai M.Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer[J].Gan To Kagaku Ryoho,2002,29(12):2209-2212.
  • 5Hirata S,Yatsuyanagi E,Yamazaki H,et al.Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone[J].Gan To Kagaku Ryoho,2000,27 (2):221-226.
  • 6Yamanaka H,Motohiro T,Michiura T,et al.Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer[J].Jpn J Thorac Cardiovasc Surg,1998,46 (10):943-948.
  • 7Yoshioka T,Gamoh M,Shineha R,et al.A new combination chemotherapy with cis-diammine-glycolatoplatinum(Nedaplatin)and 5-fluorouracil for advanced esophageal cancers[J].Intern Med,1999,38 (11):844-848.
  • 8Inuyama Y,Miyake H,Horiuchi M,et al.A late phase Ⅱ clinical study of cis-diammine glycolato platinum,254-S,for head and neck cancers[J].Gan To Kagaku Ryoho,1992,19(6):871-877.
  • 9Ota K.Nedaplatin[J].Gan To Kagaku Ryoho,1996,23(3):379-387.
  • 10Taguchi T,Wakui A,Nabeya K,et al.A phase Ⅱ clinical study of cis-diammine glycolato platinun,254-S,for gastrointestinal cancers.254-S Gastrointestinal Cancer Study Group[J].Gan To Kagaku Ryoho,1992,19(4):483-488.

共引文献67

同被引文献87

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部